Mr. Brendan F. Boyle of Pennsylvania (for himself, Mr. Marshall, Mr. Veasey, and Mr. Fortenberry) introduced the following bill; which was referred to the Committee on Energy and Commerce
To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome, Nipah, and Rift Valley fever.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act. H.R. 4553. 116th
Cong., 1st
sess., Introduced in House September 27, 2019. https://www.govinfo.gov/app/details/BILLS-116hr4553ih.
APA
Congress, House of Representatives (2019, September 27). Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act (H.R. 4553 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-116hr4553ih.
MLA
United States, Congress, House of Representatives. Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-116hr4553ih. 116th Congress, H.R. 4553, Introduced in House 27 Sep. 2019.
Bluebook
H.R.4553 - 116th Congress (2019-2020): Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act, H.R.4553, 116th Cong. (2019), https://www.govinfo.gov/app/details/BILLS-116hr4553ih.
